The role of HBsAg quantification for monitoring natural history and treatment outcome
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of HBsAg quantification for monitoring natural history and treatment outcome
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 33, Issue -, Pages 125-132
Publisher
Wiley
Online
2013-01-03
DOI
10.1111/liv.12075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy
- (2012) Jinjun Chen et al. ANTIVIRAL THERAPY
- High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
- (2012) Tai–Chung Tseng et al. GASTROENTEROLOGY
- New perspectives in the therapy of chronic hepatitis B
- (2012) Pietro Lampertico et al. GUT
- 524 RESPONSE-GUIDED PEGINTERFERON ALFA-2A THERAPY BASED ON HBSAG LEVELS AT WEEK 12 AND WEEK 24 OR 48 IMPROVES RESPONSE RATES IN HBEAG-NEGATIVE, GENOTYPE D PATIENTS
- (2012) P. Lampertico et al. JOURNAL OF HEPATOLOGY
- Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a
- (2012) Vincent Rijckborst et al. JOURNAL OF HEPATOLOGY
- High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis B
- (2012) Wai-Kay Seto et al. PLoS One
- Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
- (2011) Y. Liang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype
- (2011) Milan J Sonneveld et al. ANTIVIRAL THERAPY
- Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review
- (2011) Yun-Fan Liaw HEPATOLOGY
- Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir
- (2011) Jung Min Lee et al. HEPATOLOGY
- Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
- (2011) Y.-F. Liaw et al. HEPATOLOGY
- Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum
- (2011) Karsten Wursthorn et al. JOURNAL OF CLINICAL VIROLOGY
- A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B
- (2011) Milan J. Sonneveld et al. JOURNAL OF CLINICAL VIROLOGY
- 360 DEFINITION OF INACTIVE HEPATITIS B CARRIER BY SERUM HBSAG AND HBV DNA LEVELS – A LONG-TERM FOLLOW-UP STUDY ON HBSAG SEROCLEARANCE
- (2011) H.L.-Y. Chan et al. JOURNAL OF HEPATOLOGY
- Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
- (2011) Henry Lik-Yuen Chan et al. JOURNAL OF HEPATOLOGY
- 69 NEPTUNE STUDY: ON-TREATMENT HBSAG LEVEL ANALYSIS CONFIRMS PREDICTION OF RESPONSE OBSERVED IN PHASE 3 STUDY OF PEGINTERFERON ALFA-2A IN HBEAG-POSITIVE PATIENTS
- (2011) E. Gane et al. JOURNAL OF HEPATOLOGY
- Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B
- (2011) Myoung Hee Lee et al. JOURNAL OF MEDICAL VIROLOGY
- Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients
- (2011) A. Gramenzi et al. JOURNAL OF VIRAL HEPATITIS
- Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B
- (2010) H. L.-Y. Chan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
- (2010) Maurizia Rossana Brunetto et al. GASTROENTEROLOGY
- Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
- (2010) E. Jenny Heathcote et al. GASTROENTEROLOGY
- The natural history of chronic hepatitis B virus infection
- (2010) Brian J. McMahon HEPATOLOGY
- Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels
- (2010) Vincent Rijckborst et al. HEPATOLOGY
- A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B
- (2010) Henry Lik-Yuen Chan et al. HEPATOLOGY
- Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline
- (2010) Milan J. Sonneveld et al. HEPATOLOGY
- Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients
- (2010) Karsten Wursthorn et al. HEPATOLOGY
- Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
- (2010) Alexander J.V. Thompson et al. HEPATOLOGY
- Further analysis is required to identify an early stopping rule for peginterferon therapy that is valid for all hepatitis B e antigen-positive patients
- (2010) Teerha Piratvisuth et al. HEPATOLOGY
- On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
- (2010) Wei Cai et al. JOURNAL OF CLINICAL VIROLOGY
- Peginterferon for chronic hepatitis B: Predicting success with on-treatment benchmarks
- (2010) Rami Moucari JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 98 EXTENDED (2 YEARS) TREATMENT WITH PEGINTERFERON ALFA-2A [40KD] IMPROVES SUSTAINED RESPONSE RATES IN GENOTYPE D PATIENTS WITH HBEAG NEGATIVE CHRONIC HEPATITIS B
- (2010) P. Lampertico et al. JOURNAL OF HEPATOLOGY
- Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
- (2010) Tin Nguyen et al. JOURNAL OF HEPATOLOGY
- Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
- (2010) Jerzy Jaroszewicz et al. JOURNAL OF HEPATOLOGY
- Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir
- (2010) Jurriën G.P. Reijnders et al. JOURNAL OF HEPATOLOGY
- Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a
- (2009) Rami Moucari et al. ANTIVIRAL THERAPY
- Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
- (2009) Patrick Marcellin et al. GASTROENTEROLOGY
- Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B
- (2009) Pisit Tangkijvanich et al. JOURNAL OF CLINICAL VIROLOGY
- 917 ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B
- (2009) G.K.K. Lau et al. JOURNAL OF HEPATOLOGY
- High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
- (2009) Rami Moucari et al. JOURNAL OF HEPATOLOGY
- Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
- (2008) George V. Papatheodoridis et al. HEPATOLOGY
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
- (2008) Rami Moucari et al. HEPATOLOGY
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
- (2008) Maurizia Rossana Brunetto et al. HEPATOLOGY
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- (2008) Patrick Marcellin et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started